MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disease and has been listed as a global priority public health problem (Ren and Qu, 2023), and its pathogenesis is related to the hyperphosphorylation of tau protein and Aβ deposition.